Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 1

2(28.6%)

Phase 2

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(3)

Phase 1(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07378423Not ApplicableRecruiting

Questionnaire on Congenital Cancer Signs Through Self-Assessment

Role: collaborator

NCT04997317Phase 1Recruiting

Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Role: collaborator

NCT06274879Phase 2Not Yet Recruiting

Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

Role: collaborator

NCT02646527Not ApplicableCompleted

Dignity Therapy+: A Brief Psychological and Existential Intervention for Dying Patients and Their Families.

Role: collaborator

NCT00107081Phase 3Terminated

Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Role: collaborator

NCT01683370Completed

Pediatric FN Definition 2012 Bern

Role: collaborator

NCT03651921Not ApplicableCompleted

Testing of the Cancer Thriving and Surviving Breast Cancer Program

Role: collaborator

NCT00744640Phase 1Completed

Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma

Role: collaborator

NCT00364078Completed

Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care

Role: collaborator

All 9 trials loaded